See our latest stories

written by our lovely staff members

Pablo Cabello: “Reducing ApoE4 in Carriers is a Therapeutic Goal in Alzheimer’s Disease”

Dr. Pablo Cabello Albendea, from the Hospital Ramón y Cajal, emphasizes the importance of reducing the levels of the APOE4 protein in carriers to...

Biocross: “A Simple Test Can Identify the Risk or Prognosis of Developing Alzheimer’s in the Futur

The company Biocross has developed two innovative blood tests, e4Risk® and e4Quant®, which identify and quantify the presence of the APOE4 gene, related to...

Apoe4: A new genetic cause of Alzheimer’s discovered that affects more than 2% of the population

The Research Institute of the Hospital de la Santa Creu i Sant Pau in Barcelona has identified a new genetic form of Alzheimer's: the...